Charoen Pokphand Indonesia Tbk vs Charlie Hospital Semarang Tbk. — how do they compare? Charoen Pokphand Indonesia Tbk trades at Rp3,110 (market cap 50.34T, 2.16M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 678.4B, 10.86M 24h volume). The key difference: Charoen Pokphand Indonesia Tbk is far larger — about 74.2× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (10.86M versus 2.16M). Which is the better fit depends on your goals.
| CPIN | RSCH | |
|---|---|---|
Market Cap | 50.34T | 678.4B |
Volume | 2.16M | 10.86M |
Lot | 21.6K | 108.61K |
Turnover | 6.7B | 2.79B |
Average Price | 3,100.88 | 256.9 |
Value | 6.7B | 2.79B |
Indicative Equilibrium Price | 3,070 | 258 |
Indicative Equilibrium Volume | 141.2K | 9 |
Trailing returns across standard periods
Latest headlines on both assets
PT Charoen Pokphand Indonesia Tbk (the Company) was established in Indonesia within the framework of Foreign Investment Law No. 1 year 1967 based on Notarial Deed No. 6 dated January 7, 1972 of Drs. Gde ngurah Rai, S.H. PT Charoen Pokphand Indonesia (CPI) established by CP Overseas Investment Co. Ltd., Hongkong. CPI is one of Indonesia leading agribusiness companies, with a clear focus on the formulation and production of poultry feed and the breeding of top quality poultry stock for Indonesian market. CPI is supported by expertise and experience of the established Charoen Pokphand Group of Thailand. The company has a fabrication plant, research and development facilities and breeding centers.
Read more on CPIN →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →